Sign up
Quantellect · Congress · Issuer Profile
NASDAQ: UTHRUnited Therapeutics Corporation
HealthcareMkt Cap $25.68BCongress ownership rank #488

United Therapeutics Corporation Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 54 trades in United Therapeutics Corporation (NASDAQ: UTHR) since 2015, across 4 members, worth an estimated $3.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 27 buys against 27 sells, an evenly split skew, with Democratic members responsible for 4% of the trades and Republican members 96%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. United Therapeutics Corporation's current Quantellect Tide Score is 30 out of 100 (Calm Tide), Bottom 6% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the United Therapeutics Corporation (UTHR) stock overview and the complete trade table below.

Trades
0
Politicians
0
Filings
0
Disclosed Vol
$0.00
Buys
0
Sells
0

Price & congressional trade timeline

Party breakdown

United Therapeutics congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
No congressional trades in this period.
Go to

United Therapeutics (UTHR) congressional trading FAQ

Can members of Congress legally trade United Therapeutics (UTHR) stock?

Yes. Members of Congress are permitted to trade individual stocks, including United Therapeutics (UTHR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional United Therapeutics (UTHR) trades public?

Yes. Every congressional trade in United Therapeutics (UTHR) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded United Therapeutics (UTHR)?

Members of Congress have disclosed 54 trades in United Therapeutics (UTHR) worth $3.1M across 4 members, according to public STOCK Act filings.

Do Democrats or Republicans trade United Therapeutics (UTHR) more?

Across disclosed United Therapeutics (UTHR) trades, 4% were by Democrats and 96% by Republicans, led by Republicans (96%).

What is United Therapeutics (UTHR)'s Tide Score?

United Therapeutics (UTHR) has a Quantellect Tide Score of 30 (Calm Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewUnited Therapeutics (UTHR) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.